Froniglutide clinical trials
How each study uses froniglutide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the froniglutide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2011 (1)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
PhaseBio Pharmaceuticals Inc. (2) · Immunoforge Co. Ltd. (1)
Often tested with
Tested in the same studies.
Liraglutide (1) · Metformin (1) · Sulfonylurea Antidiabetic Agent (1) · N,N''-sulfonylbis-urea (1)
Studies
Open first, then newest update. How each study uses froniglutide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory MyopathyRecruitingPhase 2Immunoforge Co. Ltd.NCT05833711Written as Froniglutide
- Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DMCompletedPhase 2PhaseBio Pharmaceuticals Inc.NCT01658501Written as 50 mg PB1023
- Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal FunctionCompletedPhase 1PhaseBio Pharmaceuticals Inc.NCT01478399Written as PB1023 Injection
Codes
What other systems call froniglutide · ClinicalTrials.gg INT014740
- UNII (FDA) 3V0J65M6J3FRONIGLUTIDEOne source FDA
- NCI Thesaurus C190366FroniglutideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 3V0J65M6J3 | FRONIGLUTIDE | One source FDA |
| NCI Thesaurus | C190366 | Froniglutide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.